Martin, L., Kafi, R., Zhou, X., Zhang, L., Ericsson, M., & Marchand, A. (2022). Detection of recombinant erythropoietin biosimilar Jimaixin™ after administration in healthy subjects. Drug testing and analysis, 14(1), 72. https://doi.org/10.1002/dta.3143
Chicago Style (17th ed.) CitationMartin, Laurent, Rafik Kafi, Xinmiao Zhou, Lisi Zhang, Magnus Ericsson, and Alexandre Marchand. "Detection of Recombinant Erythropoietin Biosimilar Jimaixin™ After Administration in Healthy Subjects." Drug Testing and Analysis 14, no. 1 (2022): 72. https://doi.org/10.1002/dta.3143.
MLA (9th ed.) CitationMartin, Laurent, et al. "Detection of Recombinant Erythropoietin Biosimilar Jimaixin™ After Administration in Healthy Subjects." Drug Testing and Analysis, vol. 14, no. 1, 2022, p. 72, https://doi.org/10.1002/dta.3143.